Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eisai
Eisai
Court Says Teva Can Challenge Eisai Patents, Hurting Indian Rival Ranbaxy
Bloomberg
Wed, 10/6/10 - 06:52 pm
Teva Pharmaceuticals
India
Eisai
patents
Ranbaxy
Ranbaxy Has Sole Approval to Sell Generic Aricept in U.S., Regulator Says
Bloomberg
Tue, 09/21/10 - 11:59 am
Ranbaxy
Aricept
generics
Eisai
Alzheimer's disease
No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business
Seeking Alpha
Mon, 09/20/10 - 10:58 am
blood thinners
AstraZeneca
Bristol-Myers Squibb
Bayer
Eisai
Pfizer
Sanofi
Brilinta
Portola Pharmaceuticals
Boehringer Ingelheim
Eisai's Anti-Clotting Drug May Cut Heart Risks Without Increased Bleeding
Bloomberg
Mon, 08/30/10 - 11:21 am
Eisai
anti-clotting
Eisai reports upbeat results from PhIII epilepsy study
Fierce Biotech
Tue, 08/24/10 - 06:13 pm
Eisai
clinical trials
epilepsy
Elan investor questions deal with Azur Pharma
Fierce Pharma
Thu, 08/12/10 - 11:35 am
Elan
Azur Pharma
Prialt
Eisai
A Faster Pathway to Drug Approvals
Motley Fool
Sun, 08/1/10 - 02:26 pm
Europe
FDA
drug approvals
AMA
Eli Lilly
Takeda
Pfizer
Eisai
Epix
Eisai May Start Skin-Patch Aricept U.S. Sales in 2011
Bloomberg
Tue, 07/27/10 - 10:34 am
Eisai
Alzheimer's disease
Aricept
Teva Agrees To End IP Suit Over Aricept Patent
Forbes
Wed, 07/21/10 - 08:03 am
Teva Pharmaceuticals
lawsuits
Aricept
Alzheimer's disease
generics
Eisai
Can Eisai's new Alzheimer's drug fill blockbuster shoes?
Fierce Biotech
Fri, 07/16/10 - 08:40 am
Eisai
Alzheimer's disease
Pfizer
Aricept
Eisai rethinks its game to beat China rivals
FT.com
Wed, 07/7/10 - 06:56 pm
China
Eisai
Astellas
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
Arena, Orexigen Race for a Fat Opportunity
Seeking Alpha
Tue, 07/6/10 - 10:43 am
obesity
Arena Pharmaceuticals
Orexigen
Contrave
Eisai
Will Prescription Diet Pills Become Hot - Again?
Pharmalot
Thu, 07/1/10 - 05:23 pm
diet drugs
obesity
Arena Pharmaceuticals
Eisai
Contrave
Orexigen
Eisai Will Sell Arena's Hunger-Curbing Obesity Pill in the U.S. If Cleared
Bloomberg
Thu, 07/1/10 - 05:24 pm
obesity
Eisai
Arena Pharmaceuticals
FDA Warns Drug Makers On Misleading Promotional Efforts
NASDAQ.com
Fri, 06/18/10 - 08:17 am
FDA
warnings
Cumberland
Auxilium
Dainippon Sumitomo
Eisai
Phase III Study Results Showed Eisai’s Eribulin Mesylate Significantly Improved Overall Survival in Patients with Locally Recurrent or Metastatic Breast Cancer
BusinessWire
Sun, 06/6/10 - 12:31 pm
Eisai
Eribulin Mesylate
breast cancer
Eisai’s Breast Cancer Drug Gets Priority Review
Bloomberg
Wed, 06/2/10 - 08:24 am
Eisai
FDA
breast cancer
Eribulin
Is Secrecy Hurting Drug Research?
Forbes
Tue, 06/1/10 - 09:04 am
R&D
AstraZeneca
Roche
GSK
Eisai
ONYX Pharmaceuticals
Eisai Cuts Aricept Price, Joining Glaxo, Sanofi Race in Asia
Bloomberg
Thu, 04/15/10 - 08:49 am
Eisai
Aricept
GSK
Asia
Sanofi
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
next ›
last »